The Supreme Court’s impressive appetite for IP cases dominates the forthcoming intellectual property trials and judgments in the US – with decisions in seven cases to come. The Federal Circuit will also issue two en banc decisions from PTAB appeals
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the Danish company’s injunction application